Search Results - Benjamin Haaland
- Showing 1 - 20 results of 30
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
Bayesian network meta-comparison of maintenance treatments for stage IIIb/IV non-small-cell lung cancer (NSCLC) patients with good performance status not progressing after first-li... by Pui San Tan, Gilberto Lopes, Sanchalika Acharyya, Marcel Bilger, Benjamin Haaland
Published 2015Revisão -
6
Research on Dengue During World War II Revisited by Grace E. Snow, Benjamin Haaland, Eng Eong Ooi, Duane J. Gubler
Published 2014Revisão -
7
Comparative effectiveness of approved first-line anti-angiogenic and molecularly targeted therapeutic agents in the treatment of good and intermediate risk metastatic clear cell re... by Benjamin Haaland, Akhil Chopra, Sanchalika Acharyya, André P. Fay, Gilberto Lopes
Published 2014Revisão -
8
-
9
444P Overall survival (OS) by EGFR mutation status and subtypes (Deletion 19/L858R) for first-line therapies with maintenance regimens in advanced non-small-cell lung cancer (NSCLC... by Pui San Tan, Gabriel Lima Lopes, S. Aacharyya, Marcel Bilger, Benjamin Haaland
Published 2015Artigo -
10
-
11
-
12
-
13
Hormonal Therapeutics Enzalutamide and Abiraterone Acetate in the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Post-docetaxel—an Indirect Comparison by Pui San Tan, Benjamin Haaland, Alberto J. Montero, Christos E. Kyriakopoulos, Gilberto Lopes
Published 2014Artigo -
14
-
15
-
16
Comparative Efficacy and Safety of Programmed Death-1 Pathway Inhibitors in Advanced Gastroesophageal Cancers: A Systematic Review and Network Meta-Analysis of Phase III Clinical T... by Laércio Lopes da Silva, Pedro Nazareth Aguiar, Robin Park, Eduardo Edelman Saul, Benjamin Haaland, Gilberto Lopes
Published 2021Revisão -
17
-
18
-
19
-
20
Search Tools:
Related Subjects
Medicine
Internal medicine
Oncology
Cancer
Lung cancer
Chemotherapy
Confidence interval
Economics
Biology
Hazard ratio
Immunotherapy
Meta-analysis
Surgery
Docetaxel
Environmental health
Epidermal growth factor receptor
Pathology
Afatinib
Cancer research
Colorectal cancer
Demography
Economic growth
Erlotinib
Gefitinib
Health care
Immunology
Nivolumab
Nursing
Odds ratio
Paleontology